An overview: extent of teratogenicity of common medications in fetal development
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| প্রধান লেখক: | |
|---|---|
| অন্যান্য লেখক: | |
| বিন্যাস: | গবেষণাপত্র |
| ভাষা: | English |
| প্রকাশিত: |
Brac University
2022
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | http://hdl.handle.net/10361/16602 |
| id |
10361-16602 |
|---|---|
| record_format |
dspace |
| spelling |
10361-166022022-05-16T21:01:41Z An overview: extent of teratogenicity of common medications in fetal development Islam, Humayra Akter, Raushanara Department of Pharmacy, Brac University Fetal development FDA classification Common drugs in gestation Teratogenicity Placenta Fetal BBB Fetus -- Growth. Fetus -- Development. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 55-64). Fetal development is regulated by several important factors, such as maternal physiology and health condition, lifestyle, use of different types of drugs and susceptibility to various chemical, physical, and biological agents. An imbalance, abuse, misuse, or undesirable exposure to these factors can prove to be teratogenic. Drugs can act as teratogens depending on its extent of use, gestational age at which the drug is administered and the drug’s pharmacokinetics. This is possible since most drugs can cross the placental barrier and disrupt the optimal environment of the amniotic fluid, causing birth abnormalities. Some drugs can even cross the fetal blood brain barrier and cause neurological disorders. In this review paper, the extent of teratogenicity of common gestational drugs has been explored, along with their mechanisms of action that lead to congenital deformities. Humayra Islam B. Pharmacy 2022-05-16T04:33:08Z 2022-05-16T04:33:08Z 2021 2021-10 Thesis ID 17346046 http://hdl.handle.net/10361/16602 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 64 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Fetal development FDA classification Common drugs in gestation Teratogenicity Placenta Fetal BBB Fetus -- Growth. Fetus -- Development. |
| spellingShingle |
Fetal development FDA classification Common drugs in gestation Teratogenicity Placenta Fetal BBB Fetus -- Growth. Fetus -- Development. Islam, Humayra An overview: extent of teratogenicity of common medications in fetal development |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. |
| author2 |
Akter, Raushanara |
| author_facet |
Akter, Raushanara Islam, Humayra |
| format |
Thesis |
| author |
Islam, Humayra |
| author_sort |
Islam, Humayra |
| title |
An overview: extent of teratogenicity of common medications in fetal development |
| title_short |
An overview: extent of teratogenicity of common medications in fetal development |
| title_full |
An overview: extent of teratogenicity of common medications in fetal development |
| title_fullStr |
An overview: extent of teratogenicity of common medications in fetal development |
| title_full_unstemmed |
An overview: extent of teratogenicity of common medications in fetal development |
| title_sort |
overview: extent of teratogenicity of common medications in fetal development |
| publisher |
Brac University |
| publishDate |
2022 |
| url |
http://hdl.handle.net/10361/16602 |
| work_keys_str_mv |
AT islamhumayra anoverviewextentofteratogenicityofcommonmedicationsinfetaldevelopment AT islamhumayra overviewextentofteratogenicityofcommonmedicationsinfetaldevelopment |
| _version_ |
1814308240213671936 |